Why the study?
Should glucocorticoids or andrographolides be used in the treatment of mild HFMD and enterovirus 71 infections?
Should glucocorticoids or andrographolides be used in the treatment of mild HFMD and enterovirus 71 infections?
The authors recommend against the use of glucocorticoids for mild HFMD and suggest that andrographolides should undergo clinical trials for enterovirus 71 infections.
We recommend that glucocorticoids should not be used for mild HFMD and andrographolides should undergo clinical trials for treatment of enterovirus 71 infections.
No takes yet. Share an insight, caveat, or question.
He et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: